Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: In this session 116 PD of the New York Annual Meeting the panel discusses factors which led to the development of alternative risk transfer transactions in the property and casualty markets, and review techniques used to transfer and trade insurance risks within the capital markets. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. This session discussed the considerations in performing due diligence on a reinsurance partner and the impact of deteriorating credit quality. Topics included: 1. Letters of credit 2. Arbitration and disputes. 3. Impact of mergers and acquisitions. 4. Offshore reinsurance. 5. NAIC issues.

Description: This session from the 1983 SOA Vancouver Meeting reviews the Business Mens Assurance's computerized mortality study on its reinsured business. It also discusses smoker/non-smoker mortality assumptions, surplus relief via traditional coinsurance and mod-co and TEFRA impact on reinsurance. From Record of Society of Actuaries Vol. 9, No. 3

Description: When annuity products became prevalent in the U.S., they all looked more or less the same. It was where folks put their safe retirement money, yielding modest guaranteed returns with a menu of payout options to help secure their retirement. Over time, this commoditization lead to a pricing squeeze and an exhaustive set of product options and features, exposing carriers to market and policyholder behavior risk over the past decade or so.

Description: From a session at a meeting of the Society of Actuaries held in San Diego, CA, June 22-23, 2000 This session focused on the advantages and practical applications of offshore reinsurance. Topics included: · Types of reinsurance · Brief history of the development of the offshore market · Tax and regulatory advantages · Number of reinsurers and size of market · Risks that offshore reinsurance can best address · Financial reinsurance arrangements · Impact of Regulation XXX on demand and price · Regulatory considerations · Details of the use of letters of credit

Description: The presenters will explore the current state of the North American mortality baseline and long-term improvement assumptions and determine what we can learn from the UK's approach. They will share research done by the Society of Actuaries and other organizations to describe how to build a better model, plus show the impact socio-economics and other factors have on longevity expectations. The presenters will offer suggestions for how U.S. and Canadian pension plan and insurance actuaries--and the industry itself--can best use this research to develop a better model for the risk management of pension plans and group annuities

Description: The presenters will explore the long-term care insurance product and its impact on potential transactions. Discuss why the inherent risks of this product create challenges for buyers and sellers in this market.

Description: In this session 50SM of the Montreal Spring Meeting panelists review the results of recent tax court cases that will have an impact on the tax treatment of reinsurance agreements. From the Record of the Society of Actuaries, Vol. 23, No. 2.

Description: Attendees will learn about the risks and rewards of using reinsurance as part of their business strategy. Reinsurance can be used in multiple ways including optimizing value of inforce, supporting planned sales growth, improving ROE, satisfying regulatory requirements, transferring risk, etc. The structures and solutions can take many shapes in order meet companies’ strategic and financial goals. In this session, the presenters will explore the historical and current uses of reinsurance as risk management and value creation tool and discuss developments that may impact the future use of reinsurance.